NCT03181997View on ClinicalTrials.gov

Outcomes of Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis

CompletedOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Aortic Valve StenosisMalignancy
Interventions
DEVICE

Native aortic valve

Native valve, with any transcatheter heart valve type

PROCEDURE

Transcatheter aortic valve implantation (TAVI)

Percutaneous aortic valve implantation preformed in one of these methods: transfemoral, transapical,subclavian or other.

Trial Locations (1)

Unknown

Rabin Medical Center,, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT03181997 - Outcomes of Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis | Biotech Hunter | Biotech Hunter